Physician profile
Bianca D Lambert
NPI 1932723392
$1,703.20
in general payments reported to CMS, 2019-2025
12 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.61 · 2023: $254 · 2024: $860 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.60 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.63 | 2023-2025 | |
| Novo Nordisk INC | $324.23 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $323.05 | 2022-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $101.48 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astellas Pharma US INC | $92.36 | 2023-2024 | Myrbetriq, Veozah |
| Indivior INC. | $50.70 | 2024 | Sublocade |
| Phathom Pharmaceuticals, INC. | $34.57 | 2024-2025 | Voquezna |
| Pfizer INC. | $32.41 | 2025 | |
| Roche Diagnostics Corporation | $24.29 | 2025 | Cobas Liat Analyzer |
| Glaxosmithkline, LLC. | $16.32 | 2024 | Trelegy Ellipta, Arexvy |
| Alkermes, INC. | $14.66 | 2022 | |
| Tolmar, INC. | $14.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.